title: An oral phosphodiesterase inhibitor (apremilast) for inflammatory rosacea in adults: a pilot study.
authors: Department of Dermatology, Columbia University, New York, New York.
authors: Bobbye J
authors: BJ
authors: Thompson
authors: Department of Dermatology, Columbia University, New York, New York.
authors: Megan
authors: M
authors: Furniss
authors: Department of Biostatistics, Columbia University, New York, New York.
authors: Wenjing
authors: W
authors: Zhao
authors: Department of Biostatistics, Columbia University, New York, New York.
authors: Bibhas
authors: B
authors: Chakraborty
authors: Department of Dermatology, Columbia University, New York, New York.
authors: Julian
authors: J
authors: Mackay-Wiggan
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage*; D010865:Pilot Projects; D012393:Rosacea / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D010726:Phosphodiesterase Inhibitors; D013792:Thalidomide; C505730:apremilast